VELETRI 0.5 mg, powder and solvent for solution for infusion bottle, 100 ml
Active ingredients: ÉPOPROSTÉNOL, Epoprostenol sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for infusionbottle, 100 mlintraveineuse;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VELETRI 0,5 mg, poudre et solvant pour solution pour perfusion
- Pharmaceutical form
- poudre et solvant pour solution pour perfusion
- Route of administration
- intraveineuse;voie extracorporelle autre
- Presentation description
- 1 flacon(s) de poudre en verre - 1 flacon(s) de solvant en polyéthylène basse densité (PEBD) de 100 ml
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 May 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69903585CIP75857633CIP133400958576331Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉPOPROSTÉNOLpoudre | 0,5 mg · un flacon | FT |
| ÉPOPROSTÉNOL SODIQUEpoudre | 0,531 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.